A G→A transition creates a branch point sequence and activation of a cryptic exon, resulting in the hereditary disorder neurofibromatosis 2

被引:37
作者
De Klein, A
Riegman, PHJ
Bijlsma, EK
Heldoorn, A
Muijtjens, M
den Bakker, MA
Avezaat, CJJ
Zwarthoff, EC
机构
[1] Erasmus Univ, Dept Pathol, NL-3000 DR Rotterdam, Netherlands
[2] Erasmus Univ, Dept Neurosurg, NL-3000 DR Rotterdam, Netherlands
[3] Erasmus Univ, Dept Ophthalmol, NL-3000 DR Rotterdam, Netherlands
[4] Erasmus Univ, Dept Genet & Cell Biol, NL-3000 DR Rotterdam, Netherlands
[5] Univ Amsterdam, Acad Med Ctr, Dept Human Genet, NL-1105 AZ Amsterdam, Netherlands
关键词
D O I
10.1093/hmg/7.3.393
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We describe a G-->A transition within intron 5 of the NF2 gene. This mutation creates a consensus splice branch point sequence. To our knowledge this is the first report of a mutation that creates a functional branch point sequence in a human hereditary disorder. The new branch point sequence is located 18 bp upstream of a consensus splice acceptor site. A consensus splice donor site is found 106 bp 3' of the acceptor site. As a consequence the G-->A transition results in an alternatively spliced mRNA containing an additional exon 5a of 106 bp derived from intron sequences. We cloned the mutant cDNA and show that due to an in-frame stop codon the cDNA codes for a truncated NF2 protein. The mutation was observed in three affected members of an NF2 family. In a tumour of one of the family members both alternatively spliced and wild-type mRNA were found, although the wild-type allele of the gene is absent due to an interstitial deletion on chromosome 22. We also show that immunoprecipitations reveal the presence of full-length wildtype NF2 protein in the tumour lysate. These data support the hypothesis that some degree of normal splicing of the mutant precursor RNA is taking place. It is therefore likely that this residual activity of the mutant allele explains the relatively mild phenotype in the family. These data also indicate that complete inactivation of the gene is not required for tumour formation.
引用
收藏
页码:393 / 398
页数:6
相关论文
共 20 条
[1]   Growth rate characteristics of acoustic neuromas associated with neurofibromatosis type 2 [J].
Abaza, MM ;
Makariou, E ;
Armstrong, M ;
Lalwani, AK .
LARYNGOSCOPE, 1996, 106 (06) :694-699
[2]   HIGH-FREQUENCY OF INACTIVATING MUTATIONS IN THE NEUROFIBROMATOSIS TYPE-2 GENE (NF2) IN PRIMARY MALIGNANT MESOTHELIOMAS [J].
BIANCHI, AB ;
MITSUNAGA, SI ;
CHENG, JQ ;
KLEIN, WM ;
JHANWAR, SC ;
SEIZINGER, B ;
KLEY, N ;
KLEINSZANTO, AJP ;
TESTA, JR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (24) :10854-10858
[3]   MUTATIONS IN TRANSCRIPT ISOFORMS OF THE NEUROFIBROMATOSIS-2 GENE IN MULTIPLE HUMAN TUMOR TYPES [J].
BIANCHI, AB ;
HARA, T ;
RAMESH, V ;
GAO, JZ ;
KLEINSZANTO, AJP ;
MORIN, F ;
MENON, AG ;
TROFATTER, JA ;
GUSELLA, JF ;
SEIZINGER, BR ;
KLEY, N .
NATURE GENETICS, 1994, 6 (02) :185-192
[4]   MENINGIOMAS IN 5 MEMBERS OF A FAMILY OVER 2 GENERATIONS, IN ONE MEMBER SIMULTANEOUSLY WITH ACOUSTIC NEURINOMAS [J].
DELLEMAN, JW ;
DEJONG, JGY ;
BLEEKER, GM .
NEUROLOGY, 1978, 28 (06) :567-570
[5]  
DENBAKKER MA, 1995, AM J PATHOL, V147, P1339
[6]  
DEPREZ RHL, 1994, AM J HUM GENET, V54, P1022
[7]   CYTOGENETIC, MOLECULAR-GENETIC AND PATHOLOGICAL ANALYSES IN 126 MENINGIOMAS [J].
DEPREZ, RHL ;
RIEGMAN, PH ;
VANDRUNEN, E ;
WARRINGA, UL ;
GROEN, NA ;
STEFANKO, SZ ;
KOPER, JW ;
AVEZAAT, CJJ ;
MULDER, PGH ;
ZWARTHOFF, EC ;
HAGEMEIJER, A .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1995, 54 (02) :224-235
[8]  
EVANS DGR, 1992, Q J MED, V84, P603
[9]  
Fornerod M, 1996, ONCOGENE, V13, P1801
[10]   EXON SCANNING FOR MUTATION OF THE NF2 GENE IN SCHWANNOMAS [J].
JACOBY, LB ;
MACCOLLIN, M ;
LOUIS, DN ;
MOHNEY, T ;
RUBIO, MP ;
PULASKI, K ;
TROFATTER, JA ;
KLEY, N ;
SEIZINGER, B ;
RAMESH, V ;
GUSELLA, JF .
HUMAN MOLECULAR GENETICS, 1994, 3 (03) :413-419